Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection

The infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated many challenges to find an effective drug combination for hospitalized patients with severe forms of coronavirus disease 2019 (COVID-19) pneumonia. We conducted a retrospective cohort study, including 182 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Vulturar, Damiana-Maria, Neag, Maria Adriana, Vesa, Ștefan Cristian, Maierean, Anca-Diana, Gherman, Diana, Buzoianu, Anca Dana, Orăsan, Olga Hilda, Todea, Doina-Adina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698366/
https://www.ncbi.nlm.nih.gov/pubmed/36430945
http://dx.doi.org/10.3390/ijms232214462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698366/
https://www.ncbi.nlm.nih.gov/pubmed/36430945
http://dx.doi.org/10.3390/ijms232214462

Ejemplares similares